Antiviral covalent ACE2 vesicle spray
Qian-Fang Meng, Yu Han, Pan Pan, Yu Liu, Pan Pan, Rong-Chang Chen, Heng Zhang, Lang Rao
Cell Biomaterials, doi:10.1016/j.celbio.2025.100017
Highlights d Covalent ACE2 vesicles neutralized
DECLARATION OF INTERESTS L.R. and Q.-F.M. have applied for a patent related to this study. All other authors declare that they have no competing interests.
SUPPLEMENTAL INFORMATION Supplemental information can be found online at https://doi.org/10.1016/j. celbio.2025.100017 .
Supplemental information
Antiviral covalent ACE2 vesicle spray Qian-Fang Meng, Yu Han, Yu Liu, Pan Pan, Rong-Chang Chen, Heng Zhang, and Lang Rao
Supplemental Information
Antiviral covalent ACE2 vesicle spray Qian-Fang Meng 1,5 , Yu Han 2,5 , Yu Liu 1,5 , Pan Pan 3,5 , Rong-Chang Chen 4 , Heng Zhang 3 School of Basic Medical Sciences, Guangzhou Medical University, Guangzhou 511436, China. 4 Guangzhou Institute of Respiratory Health, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510163, China. 5 These authors contributed equally. 6 Lead contact. * Correspondence: zhangheng@szbl.ac.cn (H.Z.); lrao@szbl.ac.cn (L.R.).
Supplementary Figures and Tables
References
Bouhaddou, Reuschl, Polacco, Thorne, Ummadi et al., SARS-CoV-2 variants evolve convergent strategies to remodel the host response, Cell,
doi:10.1016/j.cell.2023.08.026Cao, Jian, Wang, Yu, Song et al., Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution, Nature,
doi:10.1038/s41586-022-05644-7Chen, Zhao, Zhou, Zhu, Jiang et al., Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses, Nat. Rev. Immunol,
doi:10.1038/s41577-022-00784-3Cheng, Kalluri, Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics, Extracell. Vesicle,
doi:10.1016/j.vesic.2023.100029Copeland, The drug-target residence time model: a 10-year retrospective, Nat. Rev. Drug Discov,
doi:10.1038/nrd.2015.18El Andaloussi, Ma ¨ger, Breakefield, Wood, Extracellular vesicles: biology and emerging therapeutic opportunities, Nat. Rev. Drug Discov,
doi:10.1038/nrd3978El-Shennawy, Hoffmann, Dashzeveg, Mcandrews, Mehl et al., Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2, Nat. Commun,
doi:10.1038/s41467-021-27893-2Figure, The efficiency of FSY-ACE2-Fc, FSY-ACE2-His, and FSY-ACE2-NVs inhibiting WT SARS-CoV-2 infection in vitro. All data are presented as mean ± S.D. (n = 3). Figure S6. Antiviral effects of hACE2, ACE2-NVs and FSY-ACE2-NVs. In vitro effects of hACE2, ACE2-NVs and FSY-ACE2-NVs on inhibiting Omicron variant infection with (A) pseudoviruses and (B) live viruses. All data were presented as mean ± S.D. (n = 3). Figure S10. Dynamic light scattering analysis. (A) Mean size and (B) zeta potential of FSY-ACE2-NVs, HA-FSY-ACE2-NVs, and Sucrose-HA-FSY-ACE2-NVs. All data were presented as mean ± S.D. (n = 5). Figure S12. Blood biochemistry test. (A) alanine transaminase (ALT). (B) aspartate aminotransferase (AST). (C) alkaline phosphatase (ALP). (D) blood urea nitrogen (BUN). (E) creatinine (CRE). All data were presented as mean ± S.D
Han, Yang, Hu, Zhang, Chen et al., Covalently engineered protein minibinders with enhanced neutralization efficacy against escaping SARS-CoV-2 variants, J. Am. Chem. Soc,
doi:10.1021/jacs.1c11554Higuchi, Suzuki, Arimori, Ikemura, Mihara et al., Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2, Nat. Commun,
doi:10.1038/s41467-021-24013-yKrishnan, Jiang, Zhou, Mohapatra, Peng et al., A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering, Nat. Nanotechnol,
doi:10.1038/s41565-023-01533-wLai, Meng, Tian, Zhuang, Pan et al., A decoy microrobot that removes SARS-CoV-2 and its variants in wastewater, Cell Rep. Phys. Sci,
doi:10.1016/j.xcrp.2022.101061Li, Chen, Klauser, Li, Zheng et al., Developing covalent protein drugs via proximity-enabled reactive therapeutics, Cell,
doi:10.1016/j.cell.2020.05.028Li, Wang, Dinh, Zhu, Popowski et al., Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19, Nat. Nanotechnol,
doi:10.1038/s41565-021-00923-2Li, Zhan, Yang, Tu, Hu et al., Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody, Cell,
doi:10.1016/j.cell.2022.03.009Liu, Hu, Yan, Popowski, Cheng, Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity, Nat. Nanotechnol,
doi:10.1038/s41565-023-01580-3Liu, Ma, Cheng, Feng, Ma et al., Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity, Nat. Nanotechnol,
doi:10.1038/s41565-023-01553-6Mei, Li, Wang, Zhu, Huang et al., An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection, Nat. Mater,
doi:10.1038/s41563-023-01475-7Meng, Tai, Tian, Zhuang, Pan et al., Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates, Sci. Adv,
doi:10.1126/sciadv.adg3277Mitchell, Billingsley, Haley, Wechsler, Peppas et al., Engineering precision nanoparticles for drug delivery, Nat. Rev. Drug Discov,
doi:10.1038/s41573-020-0090-8Rao, Wu, Liu, Tian, Yu et al., Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis, Nat. Commun,
doi:10.1038/s41467-020-18626-yRao, Xia, Xu, Tian, Yu et al., Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines, Proc. Natl. Acad. Sci. USA,
doi:10.1073/pnas.2014352117Shi, Wu, Chen, Liao, Sheng et al., Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells, Nat. Mater,
doi:10.1038/s41563-024-01825-zStarr, Greaney, Hilton, Ellis, Crawford et al., Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding, Cell,
doi:10.1016/j.cell.2020.08.012Tsui, Mccrone, Lambert, Bajaj, Inward et al., Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1, Science
Urano, Itoh, Suzuki, Sasaki, Kishikawa et al., An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models, Sci. Transl. Med,
doi:10.1126/scitranslmed.adi2623Wang, Li, Ye, Wang, Lyu et al., Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment, Sci. Transl. Med,
doi:10.1126/scitranslmed.abb6981Wang, Li, Yu, Fu, Jiang et al., Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity, Science,
doi:10.1126/science.aau0810Wang, Yang, Fu, Zhu, Zheng et al., Genetically encoding fluorosulfate-l-tyrosine to react with lysine, histidine, and tyrosine via SuFEx in proteins in vivo, J. Am. Chem. Soc,
doi:10.1021/jacs.8b01087Wu, Lu, Xu, Rao, Ge, Engineered cellular vesicles displaying glycosylated nanobodies for cancer immunotherapy. An-gew, Chem. Int. Ed. Engl,
doi:10.1002/anie.202404889Xiang, Ren, Hu, Coin, Wei et al., Adding an unnatural covalent bond to proteins through proximityenhanced bioreactivity, Nat. Methods,
doi:10.1038/nmeth.2595Xu, Zhu, Wu, Liu, Yue et al., 3D-printed dendritic cell vaccines for post-surgery cancer immunotherapy, Adv. Funct. Mater,
doi:10.1002/adfm.202400507Yu, Li, Tabata, Wang, Cao et al., Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants, Chem,
doi:10.1016/j.chempr.2022.07.012Zhang, Chen, Zeng, Shen, Li et al., Virus-mimetic nanovesicles as a versatile antigen-delivery system, Proc. Natl. Acad. Sci,
doi:10.1073/pnas.1505799112Zhang, Dutta, Xiong, Chan, Chan et al., Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants, Nat. Chem. Biol,
doi:10.1038/s41589-021-00965-6Zhang, Han, Yang, Lin, Li et al., Covalently engineered nanobody chimeras for targeted membrane protein degradation, J. Am. Chem. Soc,
doi:10.1021/jacs.1c08521DOI record:
{
"DOI": "10.1016/j.celbio.2025.100017",
"ISSN": [
"3050-5623"
],
"URL": "http://dx.doi.org/10.1016/j.celbio.2025.100017",
"alternative-id": [
"S305056232500008X"
],
"article-number": "100017",
"assertion": [
{
"label": "This article is maintained by",
"name": "publisher",
"value": "Elsevier"
},
{
"label": "Article Title",
"name": "articletitle",
"value": "Antiviral covalent ACE2 vesicle spray"
},
{
"label": "Journal Title",
"name": "journaltitle",
"value": "Cell Biomaterials"
},
{
"label": "CrossRef DOI link to publisher maintained version",
"name": "articlelink",
"value": "https://doi.org/10.1016/j.celbio.2025.100017"
},
{
"label": "Content Type",
"name": "content_type",
"value": "article"
},
{
"label": "Copyright",
"name": "copyright",
"value": "© 2025 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies."
}
],
"author": [
{
"affiliation": [],
"family": "Meng",
"given": "Qian-Fang",
"sequence": "first"
},
{
"affiliation": [],
"family": "Han",
"given": "Yu",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Liu",
"given": "Yu",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Pan",
"given": "Pan",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Chen",
"given": "Rong-Chang",
"sequence": "additional"
},
{
"affiliation": [],
"family": "Zhang",
"given": "Heng",
"sequence": "additional"
},
{
"ORCID": "https://orcid.org/0000-0001-5010-0729",
"affiliation": [],
"authenticated-orcid": false,
"family": "Rao",
"given": "Lang",
"sequence": "additional"
}
],
"container-title": "Cell Biomaterials",
"container-title-short": "Cell Biomaterials",
"content-domain": {
"crossmark-restriction": true,
"domain": [
"cell.com",
"elsevier.com",
"sciencedirect.com"
]
},
"created": {
"date-parts": [
[
2025,
3,
3
]
],
"date-time": "2025-03-03T15:41:08Z",
"timestamp": 1741016468000
},
"deposited": {
"date-parts": [
[
2025,
3,
3
]
],
"date-time": "2025-03-03T15:41:24Z",
"timestamp": 1741016484000
},
"indexed": {
"date-parts": [
[
2025,
3,
4
]
],
"date-time": "2025-03-04T05:44:59Z",
"timestamp": 1741067099311,
"version": "3.38.0"
},
"is-referenced-by-count": 0,
"issued": {
"date-parts": [
[
2025,
3
]
]
},
"language": "en",
"license": [
{
"URL": "https://www.elsevier.com/tdm/userlicense/1.0/",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://www.elsevier.com/legal/tdmrep-license",
"content-version": "tdm",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://doi.org/10.15223/policy-017",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://doi.org/10.15223/policy-037",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://doi.org/10.15223/policy-012",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://doi.org/10.15223/policy-029",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
},
{
"URL": "https://doi.org/10.15223/policy-004",
"content-version": "stm-asf",
"delay-in-days": 0,
"start": {
"date-parts": [
[
2025,
3,
1
]
],
"date-time": "2025-03-01T00:00:00Z",
"timestamp": 1740787200000
}
}
],
"link": [
{
"URL": "https://api.elsevier.com/content/article/PII:S305056232500008X?httpAccept=text/xml",
"content-type": "text/xml",
"content-version": "vor",
"intended-application": "text-mining"
},
{
"URL": "https://api.elsevier.com/content/article/PII:S305056232500008X?httpAccept=text/plain",
"content-type": "text/plain",
"content-version": "vor",
"intended-application": "text-mining"
}
],
"member": "78",
"original-title": [],
"page": "100017",
"prefix": "10.1016",
"published": {
"date-parts": [
[
2025,
3
]
]
},
"published-print": {
"date-parts": [
[
2025,
3
]
]
},
"publisher": "Elsevier BV",
"reference": [
{
"DOI": "10.1016/S0140-6736(20)30185-9",
"article-title": "A novel coronavirus outbreak of global health concern",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "470",
"journal-title": "Lancet",
"key": "10.1016/j.celbio.2025.100017_bib1",
"volume": "395",
"year": "2020"
},
{
"DOI": "10.1126/science.aau0810",
"article-title": "Pulmonary surfactant-biomimetic nanoparticles potentiate heterosubtypic influenza immunity",
"author": "Wang",
"doi-asserted-by": "crossref",
"journal-title": "Science",
"key": "10.1016/j.celbio.2025.100017_bib2",
"volume": "367",
"year": "2020"
},
{
"DOI": "10.1038/s41579-023-00878-2",
"article-title": "The evolution of SARS-CoV-2",
"author": "Markov",
"doi-asserted-by": "crossref",
"first-page": "361",
"journal-title": "Nat. Rev. Microbiol.",
"key": "10.1016/j.celbio.2025.100017_bib3",
"volume": "21",
"year": "2023"
},
{
"DOI": "10.1038/s41577-022-00784-3",
"article-title": "Broadly neutralizing antibodies to SARS-CoV-2 and other human coronaviruses",
"author": "Chen",
"doi-asserted-by": "crossref",
"first-page": "189",
"journal-title": "Nat. Rev. Immunol.",
"key": "10.1016/j.celbio.2025.100017_bib4",
"volume": "23",
"year": "2023"
},
{
"DOI": "10.1016/j.cell.2022.03.009",
"article-title": "Broad neutralization of SARS-CoV-2 variants by an inhalable bispecific single-domain antibody",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "1389",
"journal-title": "Cell",
"key": "10.1016/j.celbio.2025.100017_bib5",
"volume": "185",
"year": "2022"
},
{
"DOI": "10.1021/jacs.1c11554",
"article-title": "Covalently engineered protein minibinders with enhanced neutralization efficacy against escaping SARS-CoV-2 variants",
"author": "Han",
"doi-asserted-by": "crossref",
"first-page": "5702",
"journal-title": "J. Am. Chem. Soc.",
"key": "10.1016/j.celbio.2025.100017_bib6",
"volume": "144",
"year": "2022"
},
{
"DOI": "10.1038/s41589-021-00965-6",
"article-title": "Engineered ACE2 decoy mitigates lung injury and death induced by SARS-CoV-2 variants",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "342",
"journal-title": "Nat. Chem. Biol.",
"key": "10.1016/j.celbio.2025.100017_bib7",
"volume": "18",
"year": "2022"
},
{
"DOI": "10.1038/s41586-021-03693-y",
"article-title": "BNT162b2-elicited neutralization of B.1.617 and other SARS-CoV-2 variants",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "273",
"journal-title": "Nature",
"key": "10.1016/j.celbio.2025.100017_bib8",
"volume": "596",
"year": "2021"
},
{
"DOI": "10.1038/s41586-023-06809-8",
"article-title": "Inhaled SARS-CoV-2 vaccine for single-dose dry powder aerosol immunization",
"author": "Ye",
"doi-asserted-by": "crossref",
"first-page": "630",
"journal-title": "Nature",
"key": "10.1016/j.celbio.2025.100017_bib9",
"volume": "624",
"year": "2023"
},
{
"article-title": "Imprinted SARS-CoV-2 humoral immunity induces convergent Omicron RBD evolution",
"author": "Cao",
"first-page": "521",
"journal-title": "Nature",
"key": "10.1016/j.celbio.2025.100017_bib10",
"volume": "614",
"year": "2023"
},
{
"DOI": "10.1126/science.adg6605",
"article-title": "Genomic assessment of invasion dynamics of SARS-CoV-2 Omicron BA.1",
"author": "Tsui",
"doi-asserted-by": "crossref",
"first-page": "336",
"journal-title": "Science",
"key": "10.1016/j.celbio.2025.100017_bib11",
"volume": "381",
"year": "2023"
},
{
"DOI": "10.1038/s41467-021-27893-2",
"article-title": "Circulating ACE2-expressing extracellular vesicles block broad strains of SARS-CoV-2",
"author": "El-Shennawy",
"doi-asserted-by": "crossref",
"journal-title": "Nat. Commun.",
"key": "10.1016/j.celbio.2025.100017_bib12",
"volume": "13",
"year": "2022"
},
{
"DOI": "10.1126/scitranslmed.adi2623",
"article-title": "An inhaled ACE2 decoy confers protection against SARS-CoV-2 infection in preclinical models",
"author": "Urano",
"doi-asserted-by": "crossref",
"journal-title": "Sci. Transl. Med.",
"key": "10.1016/j.celbio.2025.100017_bib13",
"volume": "15",
"year": "2023"
},
{
"DOI": "10.1126/science.aau6977",
"article-title": "The biology, function, and biomedical applications of exosomes",
"author": "Kalluri",
"doi-asserted-by": "crossref",
"journal-title": "Science",
"key": "10.1016/j.celbio.2025.100017_bib14",
"volume": "367",
"year": "2020"
},
{
"DOI": "10.1038/nrd3978",
"article-title": "Extracellular vesicles: biology and emerging therapeutic opportunities",
"author": "El Andaloussi",
"doi-asserted-by": "crossref",
"first-page": "347",
"journal-title": "Nat. Rev. Drug Discov.",
"key": "10.1016/j.celbio.2025.100017_bib15",
"volume": "12",
"year": "2013"
},
{
"DOI": "10.1021/acs.nanolett.0c02278",
"article-title": "Cellular nanosponges inhibit SARS-CoV-2 infectivity",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "5570",
"journal-title": "Nano Lett.",
"key": "10.1016/j.celbio.2025.100017_bib16",
"volume": "20",
"year": "2020"
},
{
"DOI": "10.1073/pnas.1505799112",
"article-title": "Virus-mimetic nanovesicles as a versatile antigen-delivery system",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "E6129",
"journal-title": "Proc. Natl. Acad. Sci. USA",
"key": "10.1016/j.celbio.2025.100017_bib17",
"volume": "112",
"year": "2015"
},
{
"article-title": "Engineered cellular vesicles displaying glycosylated nanobodies for cancer immunotherapy",
"author": "Wu",
"journal-title": "Angew. Chem. Int. Ed. Engl.",
"key": "10.1016/j.celbio.2025.100017_bib18",
"volume": "63",
"year": "2024"
},
{
"DOI": "10.1038/s41467-020-18626-y",
"article-title": "Hybrid cellular membrane nanovesicles amplify macrophage immune responses against cancer recurrence and metastasis",
"author": "Rao",
"doi-asserted-by": "crossref",
"journal-title": "Nat. Commun.",
"key": "10.1016/j.celbio.2025.100017_bib19",
"volume": "11",
"year": "2020"
},
{
"DOI": "10.1126/scitranslmed.abb6981",
"article-title": "Macrophage-tumor chimeric exosomes accumulate in lymph node and tumor to activate the immune response and the tumor microenvironment",
"author": "Wang",
"doi-asserted-by": "crossref",
"journal-title": "Sci. Transl. Med.",
"key": "10.1016/j.celbio.2025.100017_bib20",
"volume": "13",
"year": "2021"
},
{
"DOI": "10.1021/acsnano.4c01229",
"article-title": "Genetically Edited Cascade Nanozymes for Cancer Immunotherapy",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "12295",
"journal-title": "ACS Nano",
"key": "10.1016/j.celbio.2025.100017_bib21",
"volume": "18",
"year": "2024"
},
{
"DOI": "10.1038/s41565-023-01553-6",
"article-title": "Bacteria-derived nanovesicles enhance tumour vaccination by trained immunity",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "387",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib22",
"volume": "19",
"year": "2024"
},
{
"DOI": "10.1038/s41565-024-01753-8",
"article-title": "Designing nanotheranostics with machine learning",
"author": "Rao",
"doi-asserted-by": "crossref",
"first-page": "1769",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib23",
"volume": "19",
"year": "2024"
},
{
"DOI": "10.1073/pnas.2014352117",
"article-title": "Decoy nanoparticles protect against COVID-19 by concurrently adsorbing viruses and inflammatory cytokines",
"author": "Rao",
"doi-asserted-by": "crossref",
"first-page": "27141",
"journal-title": "Proc. Natl. Acad. Sci. USA",
"key": "10.1016/j.celbio.2025.100017_bib24",
"volume": "117",
"year": "2020"
},
{
"DOI": "10.1038/s41565-021-00923-2",
"article-title": "Cell-mimicking nanodecoys neutralize SARS-CoV-2 and mitigate lung injury in a non-human primate model of COVID-19",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "942",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib25",
"volume": "16",
"year": "2021"
},
{
"DOI": "10.1038/s41565-021-00931-2",
"article-title": "Extracellular vesicles as a next-generation drug delivery platform",
"author": "Herrmann",
"doi-asserted-by": "crossref",
"first-page": "748",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib26",
"volume": "16",
"year": "2021"
},
{
"DOI": "10.1038/s41565-023-01580-3",
"article-title": "Inhalable extracellular vesicle delivery of IL-12 mRNA to treat lung cancer and promote systemic immunity",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "565",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib27",
"volume": "19",
"year": "2024"
},
{
"DOI": "10.1126/sciadv.adg3277",
"article-title": "Inhalation delivery of dexamethasone with iSEND nanoparticles attenuates the COVID-19 cytokine storm in mice and nonhuman primates",
"author": "Meng",
"doi-asserted-by": "crossref",
"journal-title": "Sci. Adv.",
"key": "10.1016/j.celbio.2025.100017_bib28",
"volume": "9",
"year": "2023"
},
{
"article-title": "Inhalable nanocatchers for SARS-CoV-2 inhibition",
"author": "Zhang",
"journal-title": "Proc. Natl. Acad. Sci. USA",
"key": "10.1016/j.celbio.2025.100017_bib29",
"volume": "118",
"year": "2021"
},
{
"DOI": "10.1038/nrd.2015.18",
"article-title": "The drug–target residence time model: a 10-year retrospective",
"author": "Copeland",
"doi-asserted-by": "crossref",
"first-page": "87",
"journal-title": "Nat. Rev. Drug Discov.",
"key": "10.1016/j.celbio.2025.100017_bib30",
"volume": "15",
"year": "2016"
},
{
"DOI": "10.1038/nmeth.2595",
"article-title": "Adding an unnatural covalent bond to proteins through proximity-enhanced bioreactivity",
"author": "Xiang",
"doi-asserted-by": "crossref",
"first-page": "885",
"journal-title": "Nat. Methods",
"key": "10.1016/j.celbio.2025.100017_bib31",
"volume": "10",
"year": "2013"
},
{
"DOI": "10.1021/jacs.1c08521",
"article-title": "Covalently engineered nanobody chimeras for targeted membrane protein degradation",
"author": "Zhang",
"doi-asserted-by": "crossref",
"first-page": "16377",
"journal-title": "J. Am. Chem. Soc.",
"key": "10.1016/j.celbio.2025.100017_bib32",
"volume": "143",
"year": "2021"
},
{
"DOI": "10.1016/j.cell.2020.05.028",
"article-title": "Developing covalent protein drugs via proximity-enabled reactive therapeutics",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "85",
"journal-title": "Cell",
"key": "10.1016/j.celbio.2025.100017_bib33",
"volume": "182",
"year": "2020"
},
{
"DOI": "10.1021/jacs.8b01087",
"article-title": "Genetically encoding fluorosulfate-l-tyrosine to react with lysine, histidine, and tyrosine via SuFEx in proteins in vivo",
"author": "Wang",
"doi-asserted-by": "crossref",
"first-page": "4995",
"journal-title": "J. Am. Chem. Soc.",
"key": "10.1016/j.celbio.2025.100017_bib34",
"volume": "140",
"year": "2018"
},
{
"DOI": "10.1016/j.chempr.2022.07.012",
"article-title": "Accelerating PERx reaction enables covalent nanobodies for potent neutralization of SARS-CoV-2 and variants",
"author": "Yu",
"doi-asserted-by": "crossref",
"first-page": "2766",
"journal-title": "Chem",
"key": "10.1016/j.celbio.2025.100017_bib35",
"volume": "8",
"year": "2022"
},
{
"DOI": "10.1038/s41565-023-01533-w",
"article-title": "A modular approach to enhancing cell membrane-coated nanoparticle functionality using genetic engineering",
"author": "Krishnan",
"doi-asserted-by": "crossref",
"first-page": "345",
"journal-title": "Nat. Nanotechnol.",
"key": "10.1016/j.celbio.2025.100017_bib36",
"volume": "19",
"year": "2024"
},
{
"DOI": "10.1016/j.nantod.2023.101942",
"article-title": "Inhaled drug delivery: Past, present, and future",
"author": "Yue",
"doi-asserted-by": "crossref",
"journal-title": "Nano Today",
"key": "10.1016/j.celbio.2025.100017_bib37",
"volume": "52",
"year": "2023"
},
{
"DOI": "10.1038/s41573-020-0090-8",
"article-title": "Engineering precision nanoparticles for drug delivery",
"author": "Mitchell",
"doi-asserted-by": "crossref",
"first-page": "101",
"journal-title": "Nat. Rev. Drug Discov.",
"key": "10.1016/j.celbio.2025.100017_bib38",
"volume": "20",
"year": "2021"
},
{
"article-title": "3D-printed dendritic cell vaccines for post-surgery cancer immunotherapy",
"author": "Xu",
"journal-title": "Adv. Funct. Mater.",
"key": "10.1016/j.celbio.2025.100017_bib39",
"volume": "34",
"year": "2024"
},
{
"DOI": "10.1038/s41568-023-00586-2",
"article-title": "mRNA-based cancer therapeutics",
"author": "Liu",
"doi-asserted-by": "crossref",
"first-page": "526",
"journal-title": "Nat. Rev. Cancer",
"key": "10.1016/j.celbio.2025.100017_bib40",
"volume": "23",
"year": "2023"
},
{
"DOI": "10.1038/s41563-024-01825-z",
"article-title": "Lyophilized lymph nodes for improved delivery of chimeric antigen receptor T cells",
"author": "Shi",
"doi-asserted-by": "crossref",
"first-page": "844",
"journal-title": "Nat. Mater.",
"key": "10.1016/j.celbio.2025.100017_bib41",
"volume": "23",
"year": "2024"
},
{
"DOI": "10.1016/j.addr.2021.01.016",
"article-title": "Stability of lyophilized and spray dried vaccine formulations",
"author": "Preston",
"doi-asserted-by": "crossref",
"first-page": "50",
"journal-title": "Adv. Drug Deliv. Rev.",
"key": "10.1016/j.celbio.2025.100017_bib42",
"volume": "171",
"year": "2021"
},
{
"DOI": "10.1016/j.cell.2023.08.026",
"article-title": "SARS-CoV-2 variants evolve convergent strategies to remodel the host response",
"author": "Bouhaddou",
"doi-asserted-by": "crossref",
"first-page": "4597",
"journal-title": "Cell",
"key": "10.1016/j.celbio.2025.100017_bib43",
"volume": "186",
"year": "2023"
},
{
"article-title": "An inhaled bioadhesive hydrogel to shield non-human primates from SARS-CoV-2 infection",
"author": "Mei",
"first-page": "903",
"journal-title": "Nat. Mater.",
"key": "10.1016/j.celbio.2025.100017_bib44",
"volume": "22",
"year": "2023"
},
{
"DOI": "10.1038/s41578-020-00247-y",
"article-title": "A materials-science perspective on tackling COVID-19",
"author": "Tang",
"doi-asserted-by": "crossref",
"first-page": "847",
"journal-title": "Nat. Rev. Mater.",
"key": "10.1016/j.celbio.2025.100017_bib45",
"volume": "5",
"year": "2020"
},
{
"DOI": "10.1161/CIRCULATIONAHA.123.065005",
"article-title": "Inhalable stem cell exosomes promote heart repair after myocardial infarction",
"author": "Li",
"doi-asserted-by": "crossref",
"first-page": "710",
"journal-title": "Circulation",
"key": "10.1016/j.celbio.2025.100017_bib46",
"volume": "150",
"year": "2024"
},
{
"DOI": "10.1016/j.vesic.2023.100029",
"article-title": "Guidelines for clinical translation and commercialization of extracellular vesicles and exosomes based therapeutics",
"author": "Cheng",
"doi-asserted-by": "crossref",
"journal-title": "Extracell. Vesicle",
"key": "10.1016/j.celbio.2025.100017_bib47",
"volume": "2",
"year": "2023"
},
{
"DOI": "10.1016/j.cell.2020.08.012",
"article-title": "Deep mutational scanning of SARS-CoV-2 receptor binding domain reveals constraints on folding and ACE2 binding",
"author": "Starr",
"doi-asserted-by": "crossref",
"first-page": "1295",
"journal-title": "Cell",
"key": "10.1016/j.celbio.2025.100017_bib48",
"volume": "182",
"year": "2020"
},
{
"DOI": "10.1038/s41467-021-24013-y",
"article-title": "Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2",
"author": "Higuchi",
"doi-asserted-by": "crossref",
"journal-title": "Nat. Commun.",
"key": "10.1016/j.celbio.2025.100017_bib49",
"volume": "12",
"year": "2021"
},
{
"article-title": "A decoy microrobot that removes SARS-CoV-2 and its variants in wastewater",
"author": "Lai",
"journal-title": "Cell Rep. Phys. Sci.",
"key": "10.1016/j.celbio.2025.100017_bib50",
"volume": "3",
"year": "2022"
}
],
"reference-count": 50,
"references-count": 50,
"relation": {},
"resource": {
"primary": {
"URL": "https://linkinghub.elsevier.com/retrieve/pii/S305056232500008X"
}
},
"score": 1,
"short-title": [],
"source": "Crossref",
"subject": [],
"subtitle": [],
"title": "Antiviral covalent ACE2 vesicle spray",
"type": "journal-article",
"update-policy": "https://doi.org/10.1016/elsevier_cm_policy"
}
